ACTIVE SESSION TAPE Biotechnology $8M Cap Quant: EXTENDED

Why Is VivoSim Labs, Inc. (VIVS) Stock Up Today?

Updated Nov 20, 2026 5:04 AM ET · Prev Close $0.12

Pro Workspace
Last Session Price
$0.29 +142.92%
+$0.17 vs $0.12 prior close
Intraday Range
$0.17 – $0.32
Open $0.19
Relative Volume
22.06x Avg
734,593,440 sh
52-Week Range
$0.12 – $3.40
Benchmark Alpha
+144.88% vs SPY
+145.11% vs QQQ
20-Session Trend +96.3%

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

VivoSim Labs, Inc. Advancing 142.92% on 22.06x Relative Volume

VivoSim Labs, Inc. (VIVS) is advancing 142.92% (+$0.17) to $0.29 on 22.06x average session volume. Relative to benchmarks, VIVS is outperforming the S&P 500 by +144.88%. 14-day RSI stands at 75.1, keeping momentum in a overbought regime.

NEWS 70% Weight
VivoSim Labs Secures Seven-Figure Pharmaceutical Testing Agreement and Raises Fiscal 2027 Revenue Growth Expectations

VivoSim Labs, Inc. Nasdaq Vivs announced a seven-figure agreement with a top-10 global pharmaceutical company for its NAMkind human tissue testing services, prompting the company to forecast fiscal 2027 revenue growth ab

TECHNICAL 68% Weight
Moving Average Structure: Mixed Alignment

Price ($0.29) holds above both 20-day ($0.15) and 50-day ($0.18) moving averages.

Volume Confirmation
HIGH VOLUME (22.06x) Accumulation
Institutional participation confirms directional price action.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

VIVS outperforming the S&P 500 by +144.88%
VIVS Session
+142.92%
$0.29
S&P 500 (SPY)
-1.96%
$715.87
Nasdaq 100 (QQQ)
-2.19%
$645.04
Healthcare (XLV)
-2.05%
$177.46
Alpha vs SPY: +144.88% Alpha vs QQQ: +145.11% Alpha vs XLV: +144.97%

Options Flow & Execution Desk

Recent VIVS Catalyst Headlines

Verified Wire
VivoSim Fiscal Q2 Earnings Snapshot

San Diego Ap San Diego Ap VivoSim Labs, Inc. VIVS on Thursday reported a loss of 475,000 in its fiscal second quarter.

Yahoo Finance · Nov 12, 2026

1–3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$0.27
Short-term support band
Upper Bound
$0.31
Short-term resistance band
Key Inflection Level
$0.32 (session resistance)

Monitor volume expansion above 1.5x RVOL around $0.32 (session resistance) for directional breakout confirmation.

Technical Regime (VIVS)

MIXED MA TREND
RSI (14)
75.1
Overbought
20-Day SMA
$0.15
Above 20d
50-Day SMA
$0.18
Above 50d
MACD Signal
Bullish
MACD 0.00
ADX (14)
27.9
Strong trend
10d Momentum
+0.15
Positive 10-day momentum

Retail & Crowd Sentiment

Very Bullish
24h Messages
101
6.7x 7d avg
Bullish / Bearish
82.2% / 17.8%
Viral buzz
Crowd Discussion Digest

StockTwits is flooded with bullish sentiment towards $VIVS, with traders predicting price targets of $1 and beyond. The latest Yahoo Finance news reports VivoSim Labs securing a seven-figure pharmaceutical testing agreement, leading to increased revenue growth expectations for Fiscal 2027.

About VivoSim Labs, Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology …

Sector
Healthcare
Market Cap
$8M
Employees
13

Get Instant VIVS Catalyst Alerts

Receive an email alert when VIVS triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

VIVS Session & Catalyst FAQ

Why is VIVS stock up today?

VivoSim Labs, Inc. (VIVS) is advancing 142.92% (+$0.17) to $0.29 on 22.06x average session volume. Relative to benchmarks, VIVS is outperforming the S&P 500 by +144.88%. 14-day RSI stands at 75.1, keeping momentum in a overbought regime.

Is VIVS stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 22.06x relative volume (high participation). Our multi-factor model currently rates VIVS as EXTENDED. Review full valuation, quality, and timing signals on the VIVS Buy or Sell Decision Brief →

What is VIVS's intrinsic value and expected trading range?

At $0.29, VIVS's modeled 1-to-3 session range is $0.27 – $0.31, with a key inflection level at $0.32 (session resistance). Compare current price against multi-year cash flow projections in the VIVS Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for VIVS?

RSI at 75.1 indicates overbought momentum — elevated pullback risk. VIVS trades at $0.29 relative to its 20-day SMA ($0.15) and 50-day SMA ($0.18), reflecting a mixed moving-average structure.

Tradestie Flagship Research & Market Hubs